Muscle tension dysphonia. Other disorders of the musculoskeletal system and connective tissue
Conditions
Interventions
Intervention 1: Intervention group: Dry needling. Intervention 2: Control group: Voice therapy.
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age range of 18 to 65 years At least one year of singing experience Diagnosis of muscle tension dysphonia by ENT specialist and speech languagwe pathologist based on clinical examinations and video stroboscopy images
Exclusion criteria
Exclusion criteria: History of surgeries in the head, neck, and chest areas Addiction to any kind of narcotics History of respiratory allergies, sensitivities, and cardiac and pulmonary diseases History of cognitive, neurological or psychological problems Having contraindications for dry needling ( needle phobia or vascular disease) Consumption of medications including antibiotics, glucocorticoids, antihistamines, and other medications that improve blood circulation and eliminate blood stasis Pregnant and breastfeeding women Withdrawal from participation in the study for any reason Receiving other treatments concurrently with the study implementation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Singing vocal handicap index. Timepoint: At the beginning of the study and after 4 treatment sessions at the end of the final treatment session. Method of measurement: Singing vocal handicap index questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Vocal tract discomfort scale. Timepoint: At the beginning of the study and after 4 treatment sessions at the end of the final treatment session. Method of measurement: Vocal tract discomfort scale questionare.;Global rating of change scale. Timepoint: After 4 treatment sessions at the end of the final treatment session. Method of measurement: Global rating of change scale questionare.;Acoustic voice analysis. Timepoint: At the beginning of the study and after 4 treatment sessions at the end of the final treatment session. Method of measurement: Praat software. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh Saeideh Babazadeh-Zavieh
Arak University of Medical Sciences
Outcome results
None listed